Live News EQUITY M impact Jun 25, 2026, 11:00 AM UTC

AGEN Presents Survival Data

Agenus announces three-year survival data from Phase 1b BOT+BAL study in MSS metastatic colorectal cancer to be presented at ESMO GI 2026

SQUAWKNEWS Updated Jun 25, 2026, 11:00 AM UTC

AGEN Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026